Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: To evaluate contrast sensitivity function (CSF) in convalescent Vogt-Koyanagi-Harada (VKH) disease and investigate the relationship between CSF and chorioretinal thickness in VKH patients with and without sunset glow fundus (SGF).

Methods: This is a cross-sectional study. Seventy-six eyes of VKH patients and 56 eyes of normal controls were evaluated. Patients were divided into SGF and non-SGF groups. The best-corrected visual acuity (BCVA) of all the participants was ≤0.0 logMAR. Their CSF and macular chorioretinal thickness were measured with quantitative CSF (qCSF) and Optical Coherence Tomography (OCT) and compared using repeated measures analysis of variance at the group level. Relationships between CSF and macular chorioretinal thickness were evaluated using generalized estimating equations.

Results: The CSF was significantly impaired in the SGF group compared to that in the control group (p = 0.001), especially at medium and high spatial frequencies. No significant CSF difference was found between the non-SGF group and control group, nor between the SGF and non-SGF groups. Compared to the controls, outer retinal thickness (ORT) in both VKH subgroups was significantly reduced (P < 0.001 or 0.005, respectively), although their outer nuclear layer thickness (ONLT) and choroidal thickness (CT) were not significantly different (both P = 1.000, P = 0.829 or 0.112, respectively). We found no significant correlation between CSF metrics and outer retinal thickness.

Conclusions: Despite good recovery of visual acuity, reduced CSF and outer retina thickness were found in convalescent VKH patients. CSF may be an important and sensitive metric to evaluate functional vision in VKH disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11751318PMC
http://dx.doi.org/10.1038/s41433-024-03418-1DOI Listing

Publication Analysis

Top Keywords

chorioretinal thickness
12
contrast sensitivity
8
sensitivity function
8
convalescent vogt-koyanagi-harada
8
vkh patients
8
sgf non-sgf
8
non-sgf groups
8
csf macular
8
macular chorioretinal
8
control group
8

Similar Publications

Purpose: To assess the effect of empagliflozin on the expression of SGLT-2 and GLUT-1 in the chorioretina of streptozotocin-induced diabetic rats.

Methods: An experimental study was performed on Wistar rats. After a 2-week adaptation period, the rats were allocated to one of four groups.

View Article and Find Full Text PDF

Purpose: To describe the multimodal imaging features of intraretinal sclero-choroidal vessels (ISCVs) in eyes with severe chorioretinal thinning.

Methods: A retrospective observational case series. We examined 6 eyes of 6 patients with advanced chorioretinal thinning presenting to the Doheny UCLA Eye Centers (pathologic myopia with posterior staphyloma, iatrogenic staphyloma, chronic anti-VEGF exposure, or non-myopic macular atrophy).

View Article and Find Full Text PDF

Intraocular Pressure and Ocular Perfusion Pressure in Central Serous Chorioretinopathy.

Am J Ophthalmol

August 2025

Fondazione Italiana Macula ETS, Genoa, Italy; Eye Clinic, Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy.

Purpose: To evaluate whether intraocular and ocular perfusion pressure (IOP and OPP, respectively) are significantly associated with central serous chorioretinopathy (CSCR) and compare their degree of disease prediction with that of anterior scleral thickness (AST).

Design: Cross-sectional study comparing cases and controls.

Subjects: 80 patients with CSCR and 80 healthy controls.

View Article and Find Full Text PDF

Purpose: To investigate retinal and choroidal optical coherence tomography (OCT) parameters in eyes with acute posterior multifocal placoid pigment epitheliopathy (APMPPE) and their changes during the follow-up.

Methods: Best corrected visual acuity (BCVA- Snellen), central macular thickness (CMT), central choroidal thickness (CCT), total choroidal area (TCA), and choroidal vascularity index (CVI) and the other clinical findings were recorded at baseline and month 1, month 3, and year 1.

Results: Twenty-two eyes of 11 patients were included in this study.

View Article and Find Full Text PDF

To describe the first use of the bispecific monoclonal antibody faricimab for sarcoid uveitis with refractory cystoid macular edema (CME). A single case was evaluated. An 82-year-old woman presented with blurred vision and signs of sarcoid uveitis bilaterally, including swollen optic discs with disc nodules, CME with chorioretinal peripheral lesions in the right eye and segmental periphlebitis in the left eye.

View Article and Find Full Text PDF